Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04697823 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Hyaluronan-enriched Medium on the Cumulative Ongoing Pregnancy Rate.

Study acronym: TETHER
StatusRecruiting
PhaseNot applicable
SponsorKU Leuven
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jan 1, 2025 to Dec 31, 2026
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    v6
  2. Primary completion date: Jan 1, 2024 to Jan 1, 2025
    • Study completion date: Dec 31, 2024 to Dec 31, 2025
    v5
  3. 2 versions Re-verified since Mar 10, 2022, no change to tracked fieldsv3-v4
  4. Trial status: Not Yet Recruiting to Recruitingv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
KU Leuven
69 trials monitored
See all monitored trials
Assessing whether the use of hyaluronan-enriched transfer medium can increase the cumulative ongoing pregnancy rate
Trial Details
NCT Number NCT04697823
Lead Sponsor KU Leuven
Conditions
(from sponsor)		 Hyaluronan-EnRiched Medium, Randomized Controlled Trial
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov